{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T23:55:51Z","timestamp":1790207751933,"version":"4.1.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T00:00:00Z","timestamp":1771545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T00:00:00Z","timestamp":1771545600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1007\/s10620-026-09720-0","type":"journal-article","created":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T08:35:09Z","timestamp":1771576509000},"page":"3044-3059","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["VPS33A Promotes Pemigatinib Resistance in Cholangiocarcinoma via Autophagy"],"prefix":"10.1007","volume":"71","author":[{"given":"Mengyu","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Man","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bolin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yushi","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanggen","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,20]]},"reference":[{"key":"9720_CR1","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1016\/j.ccell.2025.05.017","volume":"43","author":"F Huang","year":"2025","unstructured":"Huang F, Liu Z, Song Y et al. Bile acids activate cancer-associated fibroblasts and induce an immunosuppressive microenvironment in cholangiocarcinoma. Cancer Cell 2025;43:1460-1475.e10. https:\/\/doi.org\/10.1016\/j.ccell.2025.05.017.","journal-title":"Cancer Cell"},{"key":"9720_CR2","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1016\/j.jhep.2014.01.021","volume":"60","author":"J Bridgewater","year":"2014","unstructured":"Bridgewater J, Galle PR, Khan SA et al. Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma. J Hepatol 2014;60:1268\u201389. https:\/\/doi.org\/10.1016\/j.jhep.2014.01.021.","journal-title":"J Hepatol"},{"key":"9720_CR3","doi-asserted-by":"publisher","first-page":"4154","DOI":"10.1158\/1078-0432.Ccr-18-0078","volume":"24","author":"MA Lowery","year":"2018","unstructured":"Lowery MA, Ptashkin R, Jordan E et al. Comprehensive molecular profiling of intrahepatic and extrahepatic cholangiocarcinomas: potential targets for intervention. Clin. Cancer Res. 2018;24:4154\u20134161. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-18-0078.","journal-title":"Clin. Cancer Res."},{"key":"9720_CR4","doi-asserted-by":"publisher","first-page":"253","DOI":"10.21037\/hbsn-20-475","volume":"11","author":"N Munugala","year":"2022","unstructured":"Munugala N, Maithel SK. Shroff R T Novel biomarkers and the future of targeted therapies in cholangiocarcinoma: a narrative review. Hepatobiliary Surg Nutr 2022;11:253\u2013266. https:\/\/doi.org\/10.21037\/hbsn-20-475.","journal-title":"Hepatobiliary Surg Nutr"},{"key":"9720_CR5","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/s1470-2045(20)30109-1","volume":"21","author":"GK Abou-Alfa","year":"2020","unstructured":"Abou-Alfa GK, Sahai V, Hollebecque A et al. Pemigatinib for previously treated, locally advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 study. Lancet Oncol. 2020;21:671\u2013684. https:\/\/doi.org\/10.1016\/s1470-2045(20)30109-1.","journal-title":"Lancet Oncol."},{"key":"9720_CR6","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1038\/s41571-023-00770-1","volume":"20","author":"SI Ilyas","year":"2023","unstructured":"Ilyas SI, Affo S, Goyal L et al. Cholangiocarcinoma\u2014novel biological insights and therapeutic strategies. Nat Rev Clin Oncol 2023;20:470\u2013486. https:\/\/doi.org\/10.1038\/s41571-023-00770-1.","journal-title":"Nat Rev Clin Oncol"},{"key":"9720_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2024.104464","volume":"202","author":"L Gnagni","year":"2024","unstructured":"Gnagni L, Ruscito I, Zizzari IG et al. Precision oncology targeting FGFRs: a systematic review on pre-clinical activity and clinical outcomes of pemigatinib. Crit Rev Oncol Hematol 2024;202:104464. https:\/\/doi.org\/10.1016\/j.critrevonc.2024.104464.","journal-title":"Crit Rev Oncol Hematol"},{"key":"9720_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21020421","author":"F Vasilev","year":"2020","unstructured":"Vasilev F, Sukhomyasova A, Otomo T. Mucopolysaccharidosis-plus syndrome. Int J Mol Sci. 2020. https:\/\/doi.org\/10.3390\/ijms21020421.","journal-title":"Int J Mol Sci"},{"key":"9720_CR9","doi-asserted-by":"publisher","first-page":"4188","DOI":"10.1074\/jbc.RA118.005947","volume":"294","author":"RS Saleeb","year":"2019","unstructured":"Saleeb RS, Kavanagh DM, Dun AR et al. A VPS33A-binding motif on syntaxin 17 controls autophagy completion in mammalian cells. J Biol Chem 2019;294:4188\u20134201. https:\/\/doi.org\/10.1074\/jbc.RA118.005947.","journal-title":"J Biol Chem"},{"key":"9720_CR10","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1091\/mbc.E13-08-0447","volume":"25","author":"P Jiang","year":"2014","unstructured":"Jiang P, Nishimura T, Sakamaki Y et al. The HOPS complex mediates autophagosome-lysosome fusion through interaction with syntaxin 17. Mol Biol Cell 2014;25:1327\u201337. https:\/\/doi.org\/10.1091\/mbc.E13-08-0447.","journal-title":"Mol Biol Cell"},{"key":"9720_CR11","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1091\/mbc.e08-03-0282","volume":"20","author":"MA Akbar","year":"2009","unstructured":"Akbar MA, Ray S. Kr\u00e4mer H The SM protein Car\/Vps33A regulates SNARE-mediated trafficking to lysosomes and lysosome-related organelles. Mol Biol Cell 2009;20:1705\u201314. https:\/\/doi.org\/10.1091\/mbc.e08-03-0282.","journal-title":"Mol Biol Cell"},{"key":"9720_CR12","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1359\/jbmr.090409","volume":"24","author":"Y Kariya","year":"2009","unstructured":"Kariya Y, Honma M, Aoki S et al. Vps33a mediates RANKL storage in secretory lysosomes in osteoblastic cells. J. Bone Miner. Res. 2009;24:1741\u201352. https:\/\/doi.org\/10.1359\/jbmr.090409.","journal-title":"J. Bone Miner. Res."},{"key":"9720_CR13","doi-asserted-by":"publisher","DOI":"10.1007\/s13353-025-00997-x","author":"Z Cyske","year":"2025","unstructured":"Cyske Z, Rintz E, Narajczyk M et al. Cellular and molecular changes in mucopolysaccharidosis-plus syndrome caused by a homozygous c.599G > C (p.Arg200Pro) variant of the VPS33A gene. J Appl Genet. 2025. https:\/\/doi.org\/10.1007\/s13353-025-00997-x.","journal-title":"J Appl Genet"},{"key":"9720_CR14","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1073\/pnas.1118366109","volume":"109","author":"ZM Huang","year":"2012","unstructured":"Huang ZM, Chinen M, Chang PJ et al. Targeting protein-trafficking pathways alters melanoma treatment sensitivity. Proc Natl Acad Sci USA 2012;109:553\u20138. https:\/\/doi.org\/10.1073\/pnas.1118366109.","journal-title":"Proc Natl Acad Sci USA"},{"key":"9720_CR15","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1038\/s41420-023-01631-7","volume":"9","author":"H Khizar","year":"2023","unstructured":"Khizar H, Hu Y, Wu Y et al. The role and implication of autophagy in cholangiocarcinoma. Cell Death Discov 2023;9:332. https:\/\/doi.org\/10.1038\/s41420-023-01631-7.","journal-title":"Cell Death Discov"},{"key":"9720_CR16","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1038\/nrm4024","volume":"16","author":"J Kaur","year":"2015","unstructured":"Kaur J, Debnath J. Autophagy at the crossroads of catabolism and anabolism. Nat. Rev. Mol. Cell Biol. 2015;16:461\u201372. https:\/\/doi.org\/10.1038\/nrm4024.","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"9720_CR17","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s12943-020-1138-4","volume":"19","author":"X Li","year":"2020","unstructured":"Li X, He S, Ma B. Autophagy and autophagy-related proteins in cancer. Mol. Cancer 2020;19:12. https:\/\/doi.org\/10.1186\/s12943-020-1138-4.","journal-title":"Mol. Cancer"},{"key":"9720_CR18","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.molcel.2015.05.031","volume":"59","author":"DF Egan","year":"2015","unstructured":"Egan DF, Chun MG, Vamos M et al. Small molecule inhibition of the autophagy kinase ULK1 and identification of ULK1 substrates. Mol Cell 2015;59:285\u201397. https:\/\/doi.org\/10.1016\/j.molcel.2015.05.031.","journal-title":"Mol Cell"},{"key":"9720_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12020352","author":"L Liu","year":"2020","unstructured":"Liu L, Yan L, Liao N et al. A review of ULK1-mediated autophagy in drug resistance of cancer. Cancers (Basel). 2020. https:\/\/doi.org\/10.3390\/cancers12020352.","journal-title":"Cancers (Basel)"},{"key":"9720_CR20","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1158\/1541-7786.Mcr-22-0343","volume":"21","author":"S Bhattacharya","year":"2023","unstructured":"Bhattacharya S, Piya S, Ma H et al. Targeting Unc51-like Autophagy Activating Kinase 1 (ULK1) overcomes adaptive drug resistance in acute myelogenous leukemia. Mol. Cancer Res. 2023;21:548\u2013563. https:\/\/doi.org\/10.1158\/1541-7786.Mcr-22-0343.","journal-title":"Mol. Cancer Res."},{"key":"9720_CR21","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/s41572-021-00300-2","volume":"7","author":"PJ Brindley","year":"2021","unstructured":"Brindley PJ, Bachini M, Ilyas SI et al. Cholangiocarcinoma. Nat Rev Dis Primers 2021;7:65. https:\/\/doi.org\/10.1038\/s41572-021-00300-2.","journal-title":"Nat Rev Dis Primers"},{"key":"9720_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2025.217540","volume":"614","author":"X Cui","year":"2025","unstructured":"Cui X, Huang T, Jiang T et al. Current status and prospects of targeted therapy for cholangiocarcinoma based on molecular characteristics. Cancer Lett. 2025;614:217540. https:\/\/doi.org\/10.1016\/j.canlet.2025.217540.","journal-title":"Cancer Lett."},{"key":"9720_CR23","doi-asserted-by":"publisher","first-page":"4943","DOI":"10.1158\/1078-0432.Ccr-24-1834","volume":"30","author":"F Facchinetti","year":"2024","unstructured":"Facchinetti F, Loriot Y, Bray\u00e9 F et al. Understanding and overcoming resistance to selective FGFR inhibitors across FGFR2-driven malignancies. Clin. Cancer Res. 2024;30:4943\u20134956. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-24-1834.","journal-title":"Clin. Cancer Res."},{"key":"9720_CR24","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1158\/1078-0432.Ccr-23-1317","volume":"30","author":"Q Wu","year":"2024","unstructured":"Wu Q, Ellis H, Siravegna G et al. Landscape of clinical resistance mechanisms to FGFR inhibitors in FGFR2-altered cholangiocarcinoma. Clin. Cancer Res. 2024;30:198\u2013208. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-23-1317.","journal-title":"Clin. Cancer Res."},{"key":"9720_CR25","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1038\/s41571-024-00869-z","volume":"21","author":"M Katoh","year":"2024","unstructured":"Katoh M, Loriot Y, Brandi G et al. FGFR-targeted therapeutics: clinical activity, mechanisms of resistance and new directions. Nat Rev Clin Oncol 2024;21:312\u2013329. https:\/\/doi.org\/10.1038\/s41571-024-00869-z.","journal-title":"Nat Rev Clin Oncol"},{"key":"9720_CR26","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/s41419-025-07804-9","volume":"16","author":"B Zhang","year":"2025","unstructured":"Zhang B, Lu S, Xiao X et al. Targeting the ROCK2\/UBA52\/DRP1 axis enhances ferroptosis and overcomes pemigatinib resistance in Cholangiocarcinoma. Cell Death Dis 2025;16:493. https:\/\/doi.org\/10.1038\/s41419-025-07804-9.","journal-title":"Cell Death Dis"},{"key":"9720_CR27","doi-asserted-by":"publisher","first-page":"2514","DOI":"10.1093\/hmg\/ddz077","volume":"28","author":"EV Pavlova","year":"2019","unstructured":"Pavlova EV, Shatunov A, Wartosch L et al. The lysosomal disease caused by mutant VPS33A. Hum. Mol. Genet. 2019;28:2514\u20132530. https:\/\/doi.org\/10.1093\/hmg\/ddz077.","journal-title":"Hum. Mol. Genet."},{"key":"9720_CR28","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1080\/15548627.2023.2291938","volume":"20","author":"S Zhang","year":"2024","unstructured":"Zhang S, Li L, Liu X et al. The hookup model of the HOPS complex in autophagosome-lysosome fusion. Autophagy 2024;20:714\u2013715. https:\/\/doi.org\/10.1080\/15548627.2023.2291938.","journal-title":"Autophagy"},{"key":"9720_CR29","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.humpath.2010.03.015","volume":"43","author":"CH An","year":"2012","unstructured":"An CH, Kim YR, Kim HS et al. Frameshift mutations of vacuolar protein sorting genes in gastric and colorectal cancers with microsatellite instability. Hum. Pathol. 2012;43:40\u20137. https:\/\/doi.org\/10.1016\/j.humpath.2010.03.015.","journal-title":"Hum. Pathol."},{"key":"9720_CR30","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1006\/geno.1998.5340","volume":"51","author":"H Kuroyanagi","year":"1998","unstructured":"Kuroyanagi H, Yan J, Seki N et al. Human ULK1, a novel serine\/threonine kinase related to UNC-51 kinase of Caenorhabditis elegans: cDNA cloning, expression, and chromosomal assignment. Genomics 1998;51:76\u201385. https:\/\/doi.org\/10.1006\/geno.1998.5340.","journal-title":"Genomics"},{"key":"9720_CR31","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.ceb.2009.12.004","volume":"22","author":"N Mizushima","year":"2010","unstructured":"Mizushima N. The role of the Atg1\/ULK1 complex in autophagy regulation. Curr. Opin. Cell Biol. 2010;22:132\u20139. https:\/\/doi.org\/10.1016\/j.ceb.2009.12.004.","journal-title":"Curr. Opin. Cell Biol."},{"key":"9720_CR32","doi-asserted-by":"publisher","first-page":"924","DOI":"10.4161\/auto.7.8.15860","volume":"7","author":"L Shang","year":"2011","unstructured":"Shang L, Wang X. AMPK and mTOR coordinate the regulation of Ulk1 and mammalian autophagy initiation. Autophagy 2011;7:924\u20136. https:\/\/doi.org\/10.4161\/auto.7.8.15860.","journal-title":"Autophagy"},{"key":"9720_CR33","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/cr.2007.78","volume":"17","author":"Y Cao","year":"2007","unstructured":"Cao Y, Klionsky DJ. Physiological functions of Atg6\/Beclin 1: a unique autophagy-related protein. Cell Res. 2007;17:839\u201349. https:\/\/doi.org\/10.1038\/cr.2007.78.","journal-title":"Cell Res."},{"key":"9720_CR34","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1038\/s41580-023-00585-z","volume":"24","author":"J Debnath","year":"2023","unstructured":"Debnath J, Gammoh N, Ryan KM. Autophagy and autophagy-related pathways in cancer. Nat. Rev. Mol. Cell Biol. 2023;24:560\u2013575. https:\/\/doi.org\/10.1038\/s41580-023-00585-z.","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"9720_CR35","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1038\/onc.2016.333","volume":"36","author":"EE Mowers","year":"2017","unstructured":"Mowers EE, Sharifi MN, Macleod KF. Autophagy in cancer metastasis. Oncogene 2017;36:1619\u20131630. https:\/\/doi.org\/10.1038\/onc.2016.333.","journal-title":"Oncogene"},{"key":"9720_CR36","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1080\/15548627.2025.2479995","volume":"21","author":"D Chen","year":"2025","unstructured":"Chen D, Chen X, Yang M et al. H3K36me2 methyltransferase NSD2\/WHSC1 promotes triple-negative breast cancer metastasis via activation of ULK1-dependent autophagy. Autophagy 2025;21:1824\u20131842. https:\/\/doi.org\/10.1080\/15548627.2025.2479995.","journal-title":"Autophagy"},{"key":"9720_CR37","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1038\/s41388-024-03246-3","volume":"44","author":"Q Duan","year":"2025","unstructured":"Duan Q, Wang W, Xiong H et al. JAK2\/ULK1 axis promotes cervical cancer progression by autophagy induction and SRPK1 phosphorylation. Oncogene 2025;44:587\u2013600. https:\/\/doi.org\/10.1038\/s41388-024-03246-3.","journal-title":"Oncogene"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-026-09720-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10620-026-09720-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-026-09720-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T11:54:25Z","timestamp":1786017265000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10620-026-09720-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,20]]},"references-count":37,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["9720"],"URL":"https:\/\/doi.org\/10.1007\/s10620-026-09720-0","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,20]]},"assertion":[{"value":"9 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics and Research Committees of Jiangxi Cancer Hospital (protocol code 2024ky032 and date of approval is 12 March 2024), and all participants provided informed consent. Animal procedures were approved by the Animal Experimental Ethics Committee of Nanchang University.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}}]}}